Table 3. Results of multivariate Cox proportional-hazards analysis in overall patients.
Variable | For death | For recurrence-free survival | ||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% confidence interval | p | Hazard Ratio | 95% confidence interval | p | |
Age <50.00 years (VS. ≥50years) | 0.55 | 0.347 to 0.872 | 0.011 | 0.549 | 0.347 to 0.870 | 0.011 |
Gender male (VS. female) | 1.056 | 0.430 to 2.596 | 0.905 | 0.549 | 0.347 to 0.870 | 0.011 |
Clinical stage IV+III (VS. II+I) | 3.537 | 1.626 to 7.692 | 0.001 | 1.044 | 0.425 to 2.564 | 0.926 |
Tumor size ≤5.0cm | 1.403 | 0.819 to 2.401 | 0.217 | 3.501 | 1.608 to7.623 | 0.002 |
(VS.>5.0cm) | ||||||
AFP <200ng/mL (VS. ≥200ng/mL) | 1.18 | 0.643 to 2.165 | 0.593 | 1.379 | 0.807 to 2.356 | 0.24 |
Edmonson grade | 3.854 | 1.998 to 7.437 | 0 | 1.18 | 0.645 to 2.161 | 0.591 |
Low (vs.high) | ||||||
Tumor number solitary (vs. mutiple) | 0.901 | 0.531 to 1.529 | 0.699 | 3.847 | 1.992 to 7.431 | 0 |
USP22 Positive (vs. negative) | 4.981 | 2.630 to 9.434 | 0 | 0.892 | 0.526 to 1.514 | 0.673 |